Bristol Myers sales fall, cuts 2023 forecast as drugs face competition

Archive for category Home

Bristol Myers sales fall, cuts 2023 forecast as drugs face competition

Post Content

No Comments

Chile to start rate cuts, signaling more across the region

Post Content

No Comments

Bristol-Myers Squibb earnings missed by $0.23, revenue fell short of estimates

Post Content

No Comments

Baird maintains Thermo Fisher Scientific at ‘outperform’ with a price target of $625.00

Post Content

No Comments

Baird maintains Waste Management at ‘neutral’ with a price target of $170.00

Post Content

No Comments

Baird maintains RPM at ‘neutral’ with a price target of $105.00

Post Content

No Comments

Baird maintains Old Dominion Freight Line at ‘neutral’ with a price target of $410.00

Post Content

No Comments

Baird maintains TE Connectivity at ‘outperform’ with a price target of $153.00

Post Content

No Comments

Baird maintains Union Pacific at ‘outperform’ with a price target of $260.00

Post Content

No Comments

Baird maintains Ryder System at ‘neutral’ with a price target of $118.00

Post Content

No Comments

Trade with SwordSword MT5 the World #1 Trading Platform

Copyright© 2024 SWORD CAPITAL | All Rights Reserved

Sword Capital Financial Brokerage

Sword Capital Financial Brokerage regulated in Kuwait and provide the trading services Worldwide.

This is the official website for Sword Capital Financial Brokerage Globally (www.sword-capital.com).

Sword Capital Financial Brokerage Trademark is reserved worldwide, which is accredited by Sword Capital Financial Brokerage and any illegal use is held accountable in any country in the world.

Sword Capital Financial Brokerage does not offer its services to residents of certain jurisdictions such as USA, Cuba, Sudan, North Korea.

Risk Warning: Global Forex Trading involves significant risks to your invested capital. Please read and ensure you fully understand our Risk Disclosure.

Feedback

Get a Call

Live Chat

Sword
Send via WhatsApp